Key result
Cross-titration of antipsychotics while on lithium resulted in concomitant neuroleptic malignant syndrome and nephrogenic diabetes insipidus in 1 patient, causing hypovolemia and acute kidney injury.
Why the study?
An increased trend in psychiatric polypharmacy has heightened awareness of drug-drug interactions and adverse drug reactions.
Case Report (n=1)
Psychiatric polypharmacy can obscure the presentation of adverse drug reactions such as concomitant neuroleptic malignant syndrome and diabetes insipidus.
Answers are grounded in this paper and cite their sources.
Case of rare adverse events during antipsychotic cross-titration on lithium warrants vigilance in polypharmacy; leaves open prospective safety studies.
Each year, nearly one-fifth of adults in the United States are prescribed at least one psychotropic medication. An increased trend in psychiatric polypharmacy has heightened awareness of drug-drug interactions and the tracking of adverse drug reactions. This article describes a patient who developed concomitant neuroleptic malignant syndrome (NMS) and nephrogenic diabetes insipidus during cross-titration of his antipsychotics while on lithium. The patient's mild form of NMS in turn caused hypovolemia and acute kidney injury. This case study highlights the dangers of polypharmacy and how it can obscure the presentation of even classic adverse reactions.
No takes yet. Share an insight, caveat, or question.
Zaki et al. (2022) conducted a case report in Neuroleptic malignant syndrome and nephrogenic diabetes insipidus (n=1). Cross-titration of antipsychotics while on lithium was evaluated on Adverse drug reaction (NMS and diabetes insipidus). Cross-titration of antipsychotics while on lithium resulted in concomitant neuroleptic malignant syndrome and nephrogenic diabetes insipidus in 1 patient, causing hypovolemia and acute kidney injury.
Synapse has enriched 10 related papers. Consider them for comparative context: